Whitney Sutton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Whitney Sutton has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Dorry L. Segev
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
3 shared publicationsJason D. Prescott
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD
3 shared publicationsMartha A. Zeiger
Surgical Oncology Program, National Cancer Institute, National Institute of Health, Bethesda, MD, 20892, USA
3 shared publicationsAarti Mathur
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD
2 shared publications- Aarti Mathur
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
2 shared publications Joseph K. Canner
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA
2 shared publications
Latest Publications
- 16 February 2024
- Published by Elsevier in Seminars in Vascular Surgery
- Vol. 37 (1) , 82-89
Video-assisted thoracic surgery and robotic-assisted first-rib excision and thoracic outlet syndrome decompression
- 16 February 2024
- Published by Elsevier in Seminars in Vascular Surgery
- Vol. 37 (1) , 82-89
Video-assisted thoracic surgery and robotic-assisted first-rib excision and thoracic outlet syndrome decompression
- 1 January 2021
- Published by Elsevier in The American Journal of Surgery
- Vol. 221 (1) , 111-116
Is patient age associated with risk of malignancy in a ≥4 cm cytologically benign thyroid nodule?
- 1 January 2021
- Published by Elsevier in The American Journal of Surgery
- Vol. 221 (1) , 111-116
Is patient age associated with risk of malignancy in a ≥4 cm cytologically benign thyroid nodule?
- 21 May 2020
- Published by Elsevier in Journal of Surgical Research
- Vol. 254, 154-164
Treatment Variation in Older Adults With Differentiated Thyroid Cancer
- 21 May 2020
- Published by Elsevier in Journal of Surgical Research
- Vol. 254, 154-164
Treatment Variation in Older Adults With Differentiated Thyroid Cancer
- 1 January 2019
- Published by AME Publishing Company in AME Case Reports
- Vol. 3, 2
Papillary thyroid carcinoma with bilateral axillary lymph node involvement: a case report outlining hypothesis for locoregional spread and therapeutic implications
Axillary lymph node involvement (ALNI) in well differentiated papillary thyroid carcinoma (WDPTC) is a rare sequela of disease presentation. We report a case of PTC with extensive cervical lymph node involvement, local extension to the skin of the neck and bilateral ALNI without evidence of distant disease. We posit that ALNI represents local extension of disease rather than distant metastasis. Therefore, in the absence of distant spread, ALNI should result in surgical intervention. This optimizes removal of all bulky disease and increases effectiveness of radioactive iodine (RAI) therapy. Future research centered on genomics should focus on ascertaining the behavior and prognosis of such cases, especially when anatomic spread is discordant with biologic behavior.
- 1 January 2019
- Published by AME Publishing Company in AME Case Reports
- Vol. 3, 2
Papillary thyroid carcinoma with bilateral axillary lymph node involvement: a case report outlining hypothesis for locoregional spread and therapeutic implications
Axillary lymph node involvement (ALNI) in well differentiated papillary thyroid carcinoma (WDPTC) is a rare sequela of disease presentation. We report a case of PTC with extensive cervical lymph node involvement, local extension to the skin of the neck and bilateral ALNI without evidence of distant disease. We posit that ALNI represents local extension of disease rather than distant metastasis. Therefore, in the absence of distant spread, ALNI should result in surgical intervention. This optimizes removal of all bulky disease and increases effectiveness of radioactive iodine (RAI) therapy. Future research centered on genomics should focus on ascertaining the behavior and prognosis of such cases, especially when anatomic spread is discordant with biologic behavior.
- 26 April 2013
- Published by Wiley in Molecular Carcinogenesis
- Vol. 53 (10) , 841-846
Role of PTEN in basal cell derived lung carcinogenesis
Lung adenocarcinoma (AdC) and lung squamous cell carcinoma (SCC) are the most common non‐small cell lung cancer (NSCLC) subtypes, however, most genetic mouse models of lung cancer produce predominantly, if not exclusively, AdC. Whether this is secondary to targeting mutations to the distal airway cells or to the use of activating Kras mutations that drive AdC formation is unknown. We previously showed that targeting KrasG12D activation and transforming growth factor β receptor type II (TGFβRII) deletion to airway basal cells via a keratin promoter induced formation of both lung AdC and SCC. In this study we assessed if targeting phosphatase and tensin homologue (PTEN) deletion to airway basal cells could initiate lung tumor formation or increase lung SCC formation. We found that PTEN deletion is capable of initiating both lung AdC and SCC formation when targeted to basal cells and although PTEN deletion is a weaker tumor initiator than KrasG12D with low tumor multiplicity and long latency, tumors initiated by PTEN deletion were larger and displayed more malignant conversion than KrasG12D initiated tumors. That PTEN deletion did not increase lung SCC formation compared to KrasG12D activation, suggests that the initiating genetic event does not dictate tumor histology when genetic alterations are targeted to a specific cell. These studies also confirm that basal cells of the conducting airway are capable of giving rise to multiple NSCLC tumor types.
- 26 April 2013
- Published by Wiley in Molecular Carcinogenesis
- Vol. 53 (10) , 841-846
Role of PTEN in basal cell derived lung carcinogenesis
Lung adenocarcinoma (AdC) and lung squamous cell carcinoma (SCC) are the most common non‐small cell lung cancer (NSCLC) subtypes, however, most genetic mouse models of lung cancer produce predominantly, if not exclusively, AdC. Whether this is secondary to targeting mutations to the distal airway cells or to the use of activating Kras mutations that drive AdC formation is unknown. We previously showed that targeting KrasG12D activation and transforming growth factor β receptor type II (TGFβRII) deletion to airway basal cells via a keratin promoter induced formation of both lung AdC and SCC. In this study we assessed if targeting phosphatase and tensin homologue (PTEN) deletion to airway basal cells could initiate lung tumor formation or increase lung SCC formation. We found that PTEN deletion is capable of initiating both lung AdC and SCC formation when targeted to basal cells and although PTEN deletion is a weaker tumor initiator than KrasG12D with low tumor multiplicity and long latency, tumors initiated by PTEN deletion were larger and displayed more malignant conversion than KrasG12D initiated tumors. That PTEN deletion did not increase lung SCC formation compared to KrasG12D activation, suggests that the initiating genetic event does not dictate tumor histology when genetic alterations are targeted to a specific cell. These studies also confirm that basal cells of the conducting airway are capable of giving rise to multiple NSCLC tumor types.